Malignant pheochromocytoma: current status and initiatives for future progress G Eisenhofer, SR Bornstein, FM Brouwers, NKV Cheung, PL Dahia, ... Endocrine-related cancer 11 (3), 423-436, 2004 | 470 | 2004 |
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project HJ Brisse, MB McCarville, C Granata, KB Krug, SL Wootton-Gorges, ... Radiology 261 (1), 243-257, 2011 | 452 | 2011 |
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d-glucose PET1 BL Shulkin, NW Thompson, B Shapiro, IR Francis, JC Sisson Radiology 212 (1), 35-41, 1999 | 370 | 1999 |
Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force KK Matthay, B Shulkin, R Ladenstein, J Michon, F Giammarile, ... British journal of cancer 102 (9), 1319-1326, 2010 | 240 | 2010 |
Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial R Mody, A Naranjo, C Van Ryn, LY Alice, WB London, BL Shulkin, ... The lancet oncology 18 (7), 946-957, 2017 | 239 | 2017 |
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children’s oncology group GA Yanik, MT Parisi, BL Shulkin, A Naranjo, SG Kreissman, WB London, ... Journal of nuclear medicine 54 (4), 541-548, 2013 | 210 | 2013 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma SE Sharp, BL Shulkin, MJ Gelfand, S Salisbury, WL Furman Journal of Nuclear Medicine 50 (8), 1237-1243, 2009 | 206 | 2009 |
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma BL Shulkin, DM Wieland, M Schwaiger, NW Thompson, IR Francis, ... Journal of Nuclear medicine 33 (6), 1125-1131, 1992 | 202 | 1992 |
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. BL Shulkin, RJ Hutchinson, VP Castle, GA Yanik, B Shapiro, JC Sisson Radiology 199 (3), 743-750, 1996 | 186 | 1996 |
Current concepts on the diagnostic use of MIBG in children BL Shulkin, B Shapiro Journal of Nuclear Medicine 39 (4), 679-688, 1998 | 169 | 1998 |
Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma GC Mackie, BL Shulkin, RC Ribeiro, FP Worden, PG Gauger, RJ Mody, ... The Journal of Clinical Endocrinology & Metabolism 91 (7), 2665-2671, 2006 | 150 | 2006 |
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14. 18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma F Navid, PM Sondel, R Barfield, BL Shulkin, RA Kaufman, JA Allay, J Gan, ... Journal of clinical oncology 32 (14), 1445, 2014 | 146 | 2014 |
A pilot trial of humanized anti-GD2 monoclonal antibody (hu14. 18K322A) with chemotherapy and natural killer cells in children with recurrent/refractory neuroblastoma SM Federico, MB McCarville, BL Shulkin, PM Sondel, JA Hank, P Hutson, ... Clinical Cancer Research 23 (21), 6441-6449, 2017 | 143 | 2017 |
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial RE Ware, RC Rees, SA Sarnaik, RV Iyer, OA Alvarez, JF Casella, ... The Journal of pediatrics 156 (1), 66-70. e1, 2010 | 142 | 2010 |
Pilot study of iodine-131–metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma GA Yanik, JE Levine, KK Matthay, JC Sisson, BL Shulkin, B Shapiro, ... Journal of Clinical Oncology 20 (8), 2142-2149, 2002 | 141 | 2002 |
PET and PET/CT in pediatric oncology H Jadvar, LP Connolly, FH Fahey, BL Shulkin Seminars in nuclear medicine 37 (5), 316-331, 2007 | 137 | 2007 |
Targeting metabolic reprogramming by influenza infection for therapeutic intervention HS Smallwood, S Duan, M Morfouace, S Rezinciuc, BL Shulkin, A Shelat, ... Cell reports 19 (8), 1640-1653, 2017 | 136 | 2017 |
Pediatrics: diagnosis of neuroblastoma SE Sharp, MJ Gelfand, BL Shulkin Seminars in nuclear medicine 41 (5), 345-353, 2011 | 130 | 2011 |
Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: a report from the Children’s Oncology Group R Mody, LY Alice, A Naranjo, FF Zhang, WB London, BL Shulkin, ... Journal of Clinical Oncology 38 (19), 2160, 2020 | 128 | 2020 |
Resting coronary flow and coronary flow reserve in human infants after repair or palliation of congenital heart defects as measured by positron emission tomography JP Donnelly, DM Raffel, BL Shulkin, JR Corbett, EL Bove, RS Mosca, ... The Journal of Thoracic and Cardiovascular Surgery 115 (1), 103-110, 1998 | 127 | 1998 |